SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020131
Filing Date
2022-08-11
Accepted
2022-08-11 16:15:41
Documents
87
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20220630_10q.htm   iXBRL 10-Q 1667725
2 EXHIBIT 10.2 ex_407629.htm EX-10.2 31767
3 EXHIBIT 31.1 ex_387567.htm EX-31.1 17008
4 EXHIBIT 31.2 ex_387568.htm EX-31.2 16993
5 EXHIBIT 32.1 ex_387569.htm EX-32.1 6691
6 EXHIBIT 32.2 ex_387570.htm EX-32.2 6676
  Complete submission text file 0001437749-22-020131.txt   6627480

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20220630.xsd EX-101.SCH 69319
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20220630_cal.xml EX-101.CAL 51372
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20220630_def.xml EX-101.DEF 384222
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20220630_lab.xml EX-101.LAB 328486
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20220630_pre.xml EX-101.PRE 420072
81 EXTRACTED XBRL INSTANCE DOCUMENT urgn20220630_10q_htm.xml XML 903349
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 221156053
SIC: 2834 Pharmaceutical Preparations